Literature DB >> 22721661

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

Alison L Bailey, Susan S Smyth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22721661      PMCID： PMC3690140          DOI： 10.1016/j.jcin.2012.03.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  10 in total

1.  Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study.

Authors:  S E Reis; R Holubkov; A J Conrad Smith; S F Kelsey; B L Sharaf; N Reichek; W J Rogers; C N Merz; G Sopko; C J Pepine
Journal:  Am Heart J       Date:  2001-05       Impact factor: 4.749

2.  C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase.

Authors:  Erion Qamirani; Yi Ren; Lih Kuo; Travis W Hein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-17       Impact factor: 8.311

3.  In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Daniel F Pauly; B Delia Johnson; R David Anderson; Eileen M Handberg; Karen M Smith; Rhonda M Cooper-DeHoff; George Sopko; Barry M Sharaf; Sheryl F Kelsey; C Noel Bairey Merz; Carl J Pepine
Journal:  Am Heart J       Date:  2011-09-06       Impact factor: 4.749

Review 4.  Gender differences in artery wall biomechanical properties throughout life.

Authors:  Pascal Rossi; Yves Francès; Bronwyn A Kingwell; Anna A Ahimastos
Journal:  J Hypertens       Date:  2011-06       Impact factor: 4.844

5.  Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  S E Reis; R Holubkov; J S Lee; B Sharaf; N Reichek; W J Rogers; E G Walsh; A R Fuisz; R Kerensky; K M Detre; G Sopko; C J Pepine
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

6.  The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report.

Authors:  C N Merz; S F Kelsey; C J Pepine; N Reichek; S E Reis; W J Rogers; B L Sharaf; G Sopko
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

7.  The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Leslee J Shaw; C Noel Bairey Merz; Carl J Pepine; Steven E Reis; Vera Bittner; Kevin E Kip; Sheryl F Kelsey; Marian Olson; B Delia Johnson; Sunil Mankad; Barry L Sharaf; William J Rogers; Gerald M Pohost; George Sopko
Journal:  Circulation       Date:  2006-08-21       Impact factor: 29.690

8.  Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Timothy R Wessel; Christopher B Arant; Susan P McGorray; Barry L Sharaf; Steven E Reis; Richard A Kerensky; Gregory O von Mering; Karen M Smith; Daniel F Pauly; Eileen M Handberg; Sunil Mankad; Marian B Olson; B Delia Johnson; C Noel Bairey Merz; George Sopko; Carl J Pepine
Journal:  Clin Cardiol       Date:  2007-02       Impact factor: 2.882

9.  Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Gregory O von Mering; Christopher B Arant; Timothy R Wessel; Susan P McGorray; C Noel Bairey Merz; Barry L Sharaf; Karen M Smith; Marian B Olson; B Delia Johnson; George Sopko; Eileen Handberg; Carl J Pepine; Richard A Kerensky
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

10.  Relation between C reactive protein concentrations and coronary microvascular endothelial function.

Authors:  H Teragawa; Y Fukuda; K Matsuda; K Ueda; Y Higashi; T Oshima; M Yoshizumi; K Chayama
Journal:  Heart       Date:  2004-07       Impact factor: 5.994
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.